Activate Now
 
ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Patient Insights into the Design of Technology to Support a Strengths-Based Approach to Health Care.

SURVEY: Weight Management & Chronic Illness

Japanese green tea consumers have reduced risk of dementia

Do Nothing, Accomplish Everything! The Connection Between Breathing and Healing

Meet the ProHealth Editors

Best Herbs to Help With Insomnia

Choline: Why You Should Eat Your Egg Yolks and Take Krill

Calcium, vitamin D supplementation associated improved stroke recovery

Acupressure reduced fatigue in breast cancer survivors

Don't Skimp on Your Skin — Try Rosehip Oil Now

 
Print Page
Email Article

UCLA Researchers Study Cost of Popular Arthritis Drugs

  [ 121 votes ]   [ Discuss This Article ]
www.ProHealth.com • May 30, 2003


A new study demonstrates that a popular class of arthritis drugs is not as cost-effective as common painkillers in treating chronic arthritis in an average patient.

The University of California Los Angeles (UCLA) and Veterans Affairs Greater Los Angeles Healthcare System study, published in the May 20 issue of the journal Annals of Internal Medicine, shows that popular arthritis drugs developed to help avoid the gastrointestinal problems associated with anti-inflammatory drugs may not be any more cost-effective than these common painkillers. The study found that cyclooxygenase-2 selective inhibitor drugs (Coxibs) such as rofecoxib (Vioxx) and celecoxib (Celebrex) are not as cost-effective as non-steroidal anti-inflammatory drugs (NSAIDs) such as naproxen, in treating an average chronic arthritis patient. The study may lead to increased use of the less expensive NSAIDs to treat arthritis.

Coxibs offer the same pain relief, but without the gastrointestinal problems associated with taking NSAIDs. The UCLA study, however, found that this benefit did not offset the increased cost of using Coxibs to treat most arthritis. Coxibs did appear cost-effective, however, in treating the small subset of patients with a history of severe gastrointestinal complications.

UCLA's lead author, Dr. Brennan Spiegel, a fellow in gastroenterology and health services research, noted that previous studies have shown Coxibs to provide a less than 1 percent absolute risk reduction, as compared to the less costly generic NSAIDs, in the prevention of significant ulcer complications.

"We hope that this study will help guide primary-care providers, rheumatologists, pain-management physicians, health insurance companies and patients in developing the best treatment plans to meet individual needs for chronic arthritis," said senior author Dr. Ian Gralnek, assistant professor, David Geffen School of Medicine at UCLA, Veterans Affairs Greater Los Angeles Healthcare System and CURE Digestive Diseases Research Center.

More than 15 percent of Americans suffer from chronic arthritis, including osteoarthritis and rheumatoid arthritis. In the UCLA study, researchers used a sophisticated economic model to develop patient scenarios and compare the costs between Coxibs and NSAIDs.
Researchers used a standard measure used in assessing the outcome of health-care procedures or services called the quality-adjusted life year. The measurement is designed to take into account health-related quality of life as well as the duration of survival.

Researchers found that for an average 60-year-old arthritis patient with no prior gastrointestinal problems, the cost per quality-adjusted life year gained by using a Coxib compared to a NSAID is more than a quarter million dollars, or $275,809.

Spiegel notes that the general cost-effectiveness standard accepted by society, and many insurers, for treating a chronic condition like arthritis is roughly $50,000 or less per quality-adjusted life year gained.

"The cost of using Coxibs was significantly higher than we thought," Spiegel said. "Even if an insurer were willing to pay up to $150,000 per quality-adjusted life year for the use of Coxibs, only 4 percent of patients would fall into this budget -- everyone else would have much higher costs."

However, the UCLA study also found that for the small subset of arthritis patients with a history of severe gastrointestinal complications like ulcer bleeds, Coxibs proved potentially cost-effective -- at $55,803 per quality-adjusted life year.

Gralnek added that his team even strongly biased the economic model to favor Coxibs, yet the study still revealed that this class of drugs was not cost-effective for most arthritis patients. For example, in the model, any development of gastrointestinal symptoms from NSAID use was treated very aggressively, thus adding more costs to the anti-inflammatory side.

The study was funded in part by the National Institutes of Health and a Veterans Affairs Health Services Research and Development Award.



Post a Comment

Featured Products From the ProHealth Store
Mitochondria Ignite™ with NT Factor® Energy NADH™ 12.5mg Vitamin D3 Extreme™

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
Natural Pain Relief Supplements

Featured Products

Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function

Natural Remedies

D-ficient? Health Risks You Need to Know About D-ficient? Health Risks You Need to Know About
Health Benefits Are Brewing in Green Tea Health Benefits Are Brewing in Green Tea
SAM-e: a Hard-Working Molecule that May Help Ease Pain & Brighten Mood SAM-e: a Hard-Working Molecule that May Help Ease Pain & Brighten Mood
Fighting Fatigue with Ground-breaking French Oak Wood Extract Fighting Fatigue with Ground-breaking French Oak Wood Extract
Undenatured Type II Collagen - Chicken Soup for Your Joints Undenatured Type II Collagen - Chicken Soup for Your Joints

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE AND SAVE 15% NOW*
Be the first to know about new products, special discounts and the latest health news. *New subscribers only

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map